Altimmune (ALT) Debt to Equity (2012 - 2026)
Altimmune (ALT) reported Debt to Equity of $0.12 for Q1 2026, down 20.31% quarter-over-quarter from $0.15 in Q4 2025.
Altimmune (ALT) Debt to Equity (2012 - 2026) Analysis & Trends
Altimmune (ALT) has 14 years of Debt to Equity data on file, last reported at $0.12 in Q1 2026.
- Debt to Equity for Q1 2026 came in at $0.12, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $0.12 (changed N/A YoY), and the FY2025 annual result was $0.15, changed N/A from the prior year.
- Debt to Equity eased to $0.12 in Q1 2026 per ALT's latest filing, from $0.15 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.15 in Q4 2025 and troughed at $0.01 in Q2 2022.
- A 4-year average of $0.06 and a median of $0.03 in 2023 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 363.46% in 2022 and fell as far as 34.74% in 2022.
- A 4-year view of Debt to Equity shows it stood at $0.02 in 2022, then grew by 15.78% to $0.03 in 2023, then jumped by 432.62% to $0.15 in 2025, then decreased by 20.31% to $0.12 in 2026.
- Business Quant data shows ALT's Debt to Equity at $0.12 in Q1 2026, $0.15 in Q4 2025, and $0.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | 0.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.12 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.08 |
| Jun 30, 2025 | 0.09 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.03 |
| Dec 31, 2021 | 0.04 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.02 |
| Mar 31, 2020 | 0.04 |
| Dec 31, 2019 | 0.04 |